Search Results - "Pruneri G"

The prevalence and clinical implications of c-kit expression in plasma cell myeloma.

Authors: Pruneri, G. Ponzoni, M. Ferreri, A. J. M. et al.

Source: Histopathology. Apr2006, Vol. 48 Issue 5, p529-535. 7p. 12 Color Photographs, 1 Chart, 6 Graphs.

This result is not displayed to guests.
Login for full access.

Angiogenesis in myelodysplastic syndromes.

Authors: Pruneri, G Bertolini, F Soligo, D et al.

Source: British Journal of Cancer. 12/15/99, Vol. 81 Issue 8, p1398. 4p.

Conventional facilities of the linear IFMIF prototype accelerator (LIPAc).

Authors: Pruneri, G. Cara, P. Heidinger, R. et al.

Source: Fusion Engineering & Design. Nov2017, Vol. 124, p1101-1107. 7p.

Subjects: Fusion reactors, Neutron flux, Electron accelerators, Irradiation, Heating & ventilation industry

This result is not displayed to guests.
Login for full access.

The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast.

Authors: Pruneri, G. Lazzeroni, M. Bagnardi, V. et al.

Source: Annals of Oncology. Feb2017, Vol. 28 Issue 2, p321-328. 8p. 2 Charts, 3 Graphs.

Clinical validity of tumor-infiltrating lymphocytes analysis in patients with triple-negative breast cancer.

Authors: Pruneri, G. Vingiani, A. Bagnardi, V. et al.

Source: Annals of Oncology. Feb2016, Vol. 27 Issue 2, p249-256. 8p. 2 Charts, 4 Graphs.

Tissue Microarrays in Diffuse Large B-Cell Lymphomas: Are They Really Able to Identify Distinct Prognostic Groups in Lymphomas of Both Nodal and Extranodal Origin?

Authors: Laszlo, D. Pruneri, G. Andreola, G. et al.

Source: International Journal of Surgical Pathology. Aug2011, Vol. 19 Issue 4, p417-424. 8p.

Plasmablastic lymphoma: a review.

Authors: Rafaniello Raviele, P Pruneri, G Maiorano, E

Source: Oral Diseases. Jan2009, Vol. 15 Issue 1, p38-45. 8p. 1 Color Photograph, 1 Chart.

Molecular profiling of pediatric and young adult colorectal cancer reveals a distinct genomic landscapes and potential therapeutic avenues.

Authors: Busico, A. Gasparini, P. Rausa, E. et al.

Source: Scientific Reports. 6/7/2024, Vol. 14 Issue 1, p1-11. 11p.

The effect of metformin on apoptosis in a breast cancer presurgical trial.

Authors: Cazzaniga, M DeCensi, A Pruneri, G et al.

Source: British Journal of Cancer. 11/26/2013, Vol. 109 Issue 11, p2792-2797. 6p.

NPMc+ and FLT3_ITD mutations cooperate in inducing acute leukaemia in a novel mouse model.

Authors: Mallardo, M Caronno, A Pruneri, G et al.

Source: Leukemia (08876924). Nov2013, Vol. 27 Issue 11, p2248-2251. 4p.

Antitumour and biological effects of letrozole and GnRH analogue as primary therapy in premenopausal women with ER and PgR positive locally advanced operable breast cancer.

Authors: Torrisi, R. Bagnardi, V. Pruneri, G. et al.

Source: British Journal of Cancer. 9/17/2007, Vol. 97 Issue 6, p802-808. 7p. 3 Charts, 2 Graphs.

RELATIONSHIP BETWEEN MOLECULAR SUBTYPE AND CHANGE IN KI-67 IN THE PLACEBO ARMS OF WINDOW OF OPPORTUNITY TRIALS.

Authors: Pruneri, G. Gandini, S. Guerrieri-Gonzaga, A. et al.

Source: Cancer Research. Dec2012 Meeting Abstracts, Vol. 72 Issue 24a, p2107-2108. 2p.

The Ki-67 labeling index predicts the risk of recurrence of DIN patients treated with radiotherapy following breast conserving surgery.

Authors: Pruneri, G. Lazzeroni, M. Guerrieri-Gonzaga, A. et al.

Source: Cancer Research. Dec2012 Meeting Abstracts, Vol. 72 Issue 24a, p2077-2078. 2p.

ESMO Precision Oncology Working Group recommendations on the structure and quality indicators for molecular tumour boards in clinical practice.

Authors: Westphalen, C.B. Boscolo Bielo, L. Aftimos, P. et al.

Source: Annals of Oncology. Jun2025, Vol. 36 Issue 6, p614-625. 12p.

(456) - BOS and RAS Subtypes Differ in Explant Tissue Immune Subpopulations by Spatial Proteomics.

Authors: Vaira, V. Righi, I. Rosso, L. et al.

Source: Journal of Heart & Lung Transplantation. Jul2026:Supplement, Vol. 45 Issue 5, p218-218. 1p.

Association of molecular subtypes with Ki-67 changes in untreated breast cancer patients undergoing pre-surgical trials.

Authors: Gandini, S. Guerrieri-Gonzaga, A. Pruneri, G. et al.

Source: Annals of Oncology. Mar2014, Vol. 25 Issue 3, p618-623. 6p.

Daily clinical practice of fresh tumour tissue freezing and gene expression profiling; logistics pilot study preceding the MINDACT trial

Authors: Mook, S. Bonnefoi, H. Pruneri, G. et al.

Source: European Journal of Cancer. May2009, Vol. 45 Issue 7, p1201-1208. 8p.

ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer.

Authors: Tarantino, P. Viale, G. Press, M.F. et al.

Source: Annals of Oncology. Aug2023, Vol. 34 Issue 8, p645-659. 15p.